Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
15.86
-18.13 (-53.34%)
At close: Dec 2, 2025, 4:00 PM EST
16.28
+0.42 (2.65%)
After-hours: Dec 2, 2025, 7:59 PM EST
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $953.94 million as of December 2, 2025. Its market cap has decreased by -65.04% in one year.
Market Cap
953.94M
Enterprise Value
-12.39M
1-Year Change
-65.04%
Ranking
Category
Stock Price
$15.86
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $953.94M, an increase of 55.43%. That is a compound annual growth rate of 10.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 2.04B | -33.77% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | 613.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.42B |
| Johnson & Johnson | 490.58B |
| AbbVie | 396.58B |
| UnitedHealth Group | 295.97B |
| AstraZeneca | 283.73B |
| Merck & Co. | 250.36B |
| Novartis AG | 249.18B |
| Abbott Laboratories | 219.58B |